InvestorsHub Logo
Followers 62
Posts 7418
Boards Moderated 1
Alias Born 11/24/2010

Re: None

Monday, 12/21/2020 7:53:19 AM

Monday, December 21, 2020 7:53:19 AM

Post# of 1628
3:05a ET 12/21/2020 - BusinessWire
ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company
Mentioned: NK
ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced they have entered into an agreement to merge in a stock-for-stock transaction. The combination will create a leading immunotherapy and cell therapy company focused on oncology and infectious disease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBRX News